Pacemaker Infection: Symptoms, Causes, and Treatment

Pacemaker infection is an uncommon but serious complication that can develop after any cardiac implantable electronic device procedure, affecting roughly 1 in 100 patients within the first year. The infection can stay confined to the skin pocket where the device sits, or it can travel along the leads into the heart itself, causing a form of endocarditis that carries a real risk of death. What makes these infections tricky is that they don’t always announce themselves with dramatic symptoms. Some simmer quietly for months or years before producing anything obvious, and by that point the only reliable treatment is removing the entire system.

How Common Are Pacemaker Infections

In the first three months after a device procedure, infections occur at the highest rate, then taper off. A large study published in JAMA Cardiology found that the cumulative infection incidence was about 0.6% within three months and 0.9% within twelve months of a procedure.¹ That makes the first few months the highest-risk window, at roughly 0.21% per month, dropping significantly after that. Over longer time horizons, the numbers climb: a population-based study tracking patients from 1988 to 2015 found a cumulative infection probability of about 6% at fifteen years and nearly 12% at twenty-five years of follow-up.² So while the risk in any given year is low, it accumulates over the life of the device, and most pacemaker patients live with their devices for many years.

What Symptoms to Watch For

Pacemaker infections broadly fall into two categories: pocket infections and device-related endocarditis. The difference matters because the symptoms, urgency, and prognosis are not the same. In one center’s review, about a third of device infections were pocket infections, while the remaining two-thirds involved endocarditis on the leads or heart valves.³

A pocket infection stays local, at least initially. You might notice redness, warmth, swelling, or tenderness over the device site, typically on the upper chest just below the collarbone. More advanced pocket infections can produce pus discharge or a visible sinus tract. In the worst cases, the device can erode through the skin entirely, becoming partially or fully exposed.⁴ Some classification systems grade pocket complications by severity, ranging from definite pocket infection with erythema and pus to full erosion.⁵ Any skin breakdown over the device should prompt immediate medical evaluation, even if you don’t feel particularly sick.

Device-related endocarditis is the more dangerous form. Here the infection has spread along the leads into the bloodstream and heart. Symptoms tend to be systemic: fevers, chills, night sweats, fatigue, and sometimes weight loss. Because these overlap with dozens of other conditions, endocarditis can go unrecognized for weeks. Some patients present with persistent low-grade fevers and nothing else. Others develop sepsis rapidly. If bacteria shed from infected leads reach the lungs, small clots of infected material can lodge there, causing cough, chest pain, or shortness of breath. A pocket infection can coexist with endocarditis, so visible pocket changes combined with fever are a red flag that the infection has likely spread deeper.

What Causes Pacemaker Infections

The overwhelming majority of pacemaker infections are caused by staphylococcal bacteria. In one classic study of lead-related endocarditis, a pathogen was identified in about 88% of patients, and staphylococci accounted for over 93% of those.⁶ More recent data break that down further: methicillin-sensitive Staphylococcus aureus (the common staph that lives on skin) and methicillin-sensitive Staphylococcus epidermidis (a milder skin commensal) are the two most frequently cultured organisms from both blood and pocket sites.⁷

Most infections enter during the implantation procedure itself or during subsequent device replacements. Bacteria from the patient’s own skin get introduced into the pocket, settle onto the device or lead surfaces, and form biofilms. A biofilm is essentially a protective slime layer that bacteria build around themselves once they attach to a foreign surface. Electron microscopy of infected pacemaker leads has shown that the metal tip and internal wires tend to be coated in heavy bacterial biofilm, while the outer silicone surface stays relatively clear.⁸ Even devices without any clinical signs of infection can harbor bacteria: one study found that Propionibacterium acnes, a slow-growing skin bacterium, colonized roughly a quarter of explanted pacemaker devices, with most of those isolates capable of forming biofilms.⁹

This biofilm problem is central to understanding why pacemaker infections are so stubborn. Once bacteria are embedded in biofilm on a lead or generator, antibiotics alone struggle to penetrate it. That’s the fundamental reason why device removal, rather than prolonged antibiotic courses, is the standard treatment.

Who Is at Higher Risk

Some patients face a meaningfully elevated risk of infection after pacemaker implantation. A systematic review and meta-analysis identified several host-related risk factors: diabetes roughly doubled the odds, and end-stage kidney disease was associated with nearly nine times the odds of infection.¹⁰ Milder kidney impairment also increased risk, though not as dramatically. In observational data from a single center, hypertension and diabetes were the most common comorbidities among patients who developed pocket infections.¹¹ That said, the kidney disease connection may be partly manageable: one propensity-matched study found that after applying a rigorous skin antiseptic protocol, patients with chronic kidney disease had infection rates similar to those without it.¹²

Procedural factors matter just as much as patient characteristics. Pocket hematoma, a blood collection in the device pocket after the procedure, is one of the strongest modifiable risk factors. In the WRAP-IT trial, control patients who developed a hematoma had a major infection rate of about 13% during follow-up, compared to roughly 1.6% in those without hematoma, an eleven-fold increase in risk.¹³ Hematomas create a warm, blood-filled space that’s ideal for bacteria to grow in, while also potentially requiring additional interventions that introduce more contamination risk.¹⁴ Revision or replacement procedures also carry higher infection rates than first-time implants, likely because the existing scar tissue and device hardware create a more complicated surgical field.

How Pacemaker Infections Are Diagnosed

Diagnosing a pocket infection is often straightforward when you can see redness, swelling, or drainage at the device site. The challenge comes with endocarditis and with subtler presentations where the only sign is persistent fever or positive blood cultures without an obvious source. Accurate diagnosis requires a combination of physical exam, lab work, and imaging.

Blood cultures are the microbiological backbone. International consensus guidelines recommend drawing at least three sets of blood cultures, spaced at least thirty minutes apart, before starting antibiotics.¹⁵ This timing helps distinguish between a one-off skin contaminant and a genuine bloodstream infection. In stable patients, a two-to-three-day washout period off antibiotics improves the chances of capturing the pathogen. Any positive blood culture with a staphylococcal organism, even a single bottle, should be taken seriously and trigger further workup for a device infection. When cultures remain negative after standard incubation, extending the incubation period and using molecular techniques like DNA sequencing can help catch slow-growing or unusual organisms.¹⁵

Imaging plays a critical role in confirming lead involvement. Transesophageal echocardiography (a heart ultrasound done via the esophagus) is the gold standard for visualizing vegetations, which are clumps of bacteria and clot material attached to leads or heart valves. Its sensitivity for detecting lead infections is roughly 90% or better, substantially higher than standard transthoracic echocardiography done from the chest wall.¹⁶ However, echocardiography has a blind spot: it can only show what’s inside the heart and cannot distinguish infection from old clot or scar tissue on the leads. FDG-PET/CT scanning, which highlights areas of active inflammation by tracking sugar uptake, has emerged as a valuable complement. It can show infection along the entire length of leads, including portions outside the heart, and is especially useful in ambiguous cases where echo is inconclusive.¹⁷¹⁸

Treatment Requires Removing the Entire System

The single most important principle in treating a pacemaker infection is that the device and all its leads need to come out. This is true for both pocket infections and endocarditis. Antibiotics alone are not enough because of the biofilm problem: bacteria sheltered inside biofilm on hardware surfaces are essentially unreachable by intravenous drugs. A systematic review and meta-analysis comparing complete device removal to conservative treatment (antibiotics without full extraction) found that patients who had everything removed had dramatically lower relapse rates and lower mortality at both short and medium-term follow-up.¹⁹ Retaining an infected device is associated with unacceptably high relapse risk and increased death.²⁰

That sounds straightforward on paper, but lead extraction is a specialized procedure. Over the years that leads sit inside veins and the heart, scar tissue grows around them, sometimes anchoring them firmly to vessel walls. Extraction typically requires powered sheaths, tools that slide over the lead and use laser energy or mechanical cutting to free it from scar tissue. Current data show that both laser-assisted and rotational mechanical extraction achieve about a 94% complete success rate, with major complication rates under 2%.²¹ Newer mechanical cutting tools have reported similar success rates in the range of 97%.²² When one approach fails, operators can switch to another: in one series, about half of patients who started with a laser sheath needed crossover to a rotational sheath, with clinical success rates near 99% in both groups and no major complications from the powered tools.²³

After extraction, patients receive a course of intravenous antibiotics tailored to the organism identified from cultures. The duration depends on whether the infection was limited to the pocket or involved the bloodstream and heart. Pocket-only infections generally require a shorter course, while endocarditis typically calls for several weeks of intravenous treatment.

When and Where to Reimplant

Most patients who have an infected pacemaker removed still need a pacing device. The question then becomes how long to wait and where to place the new one. The old site is usually avoided to reduce the chance of reinfection, so the new device goes on the opposite side of the chest.

Timing is debated. You might expect that waiting longer after extraction would allow the infection to fully clear and reduce reinfection, but the evidence is more nuanced. A systematic review and meta-analysis found that reimplantation beyond 72 hours was associated with a trend toward higher reinfection rates, though this didn’t reach statistical significance, and when the cutoff was pushed to one week, there was no clear difference.²⁴ A multicenter database study reached a reassuring conclusion: the risk of a second infection after reimplantation is low regardless of reimplant timing.²⁵ In practice, the timing decision is individualized: someone who is pacemaker-dependent and doesn’t tolerate being without pacing will be reimplanted sooner, while a patient whose blood cultures are still growing bacteria will wait longer.

For patients who are pacemaker-dependent and can’t safely go without pacing during the interval, a temporary pacing solution bridges the gap. In some cases, clinicians have used leadless pacemakers as part of the treatment strategy, implanting them at the time of extraction so the patient doesn’t spend any time without pacing support. One reported case involved a 95-year-old pacemaker-dependent patient who received a leadless device via the neck vein during the same procedure as extraction of the infected system, allowing discharge the following day.²⁶

Preventing Infection in the First Place

Prevention starts with sterile operative technique, appropriate skin preparation, and perioperative antibiotics, all of which are standard practice. Beyond those basics, one of the most studied preventive innovations is the antibacterial envelope, a mesh pouch that wraps around the pulse generator inside the pocket and slowly releases antibiotics (rifampin and minocycline) over about a week. The landmark WRAP-IT trial, published in the New England Journal of Medicine, randomized over 6,000 patients undergoing higher-risk device procedures and found that the envelope reduced major infections by about 40% over twelve months, with an infection rate of 0.7% in the envelope group versus 1.2% in the control group.²⁷ Real-world data from pacemaker patients specifically have reinforced this: one project found an 89% reduction in infection risk with envelope use, with a cumulative infection incidence at four years of 0.4% in the envelope group compared to 2.5% without it.²⁸ Economic analyses suggest the envelope is cost-effective, particularly in patients undergoing repeat procedures who face a higher baseline risk.²⁹

Managing blood thinners around the procedure is another practical consideration. Hematoma is such a potent infection risk factor that some centers have adopted strategies to continue anticoagulation through the procedure rather than stopping and bridging it, which paradoxically can cause more bleeding. The goal is to minimize pocket hematoma by whatever approach the operating team judges safest for the individual patient.

Leadless Pacemakers and the Infection Advantage

Leadless pacemakers, tiny self-contained devices implanted directly inside the heart through a catheter in the leg vein, may fundamentally change the infection landscape. They eliminate the two main infection targets: the subcutaneous pocket and the transvenous leads. A review of the potential mechanisms noted that while transvenous pacemakers carry an expected infection rate between roughly 0.8% and 2%, no cases of leadless pacemaker infection had been reported in clinical trials enrolling over 3,000 patients.³⁰ Beyond the absence of a pocket and leads, the reduced handling of the device during implantation (less skin and glove contact), the small size, and the materials used may all contribute to infection resistance.

A retrospective comparison found that site infection occurred in about 16% of conventional pacemaker complication cases versus roughly 3% of leadless pacemaker complication cases.³¹ Leadless devices are not a universal solution, though. Current models only pace the right ventricle, which limits their use to certain rhythm disorders. Patients who need dual-chamber pacing or cardiac resynchronization therapy still require conventional systems with leads for now, though multi-chamber leadless systems are under active development.

The Financial and Physical Toll

Pacemaker infections carry costs that go well beyond the medical bills. Hospitalization for a device infection runs two-and-a-half to four times longer than an uncomplicated device procedure, with standardized stays ranging from about 15 to 24 days depending on the device type. The incremental cost of an infection added roughly $14,000 to $16,500 to a hospital admission, with total admission costs reaching $29,000 to $53,000. More than 40% of the extra cost came from intensive care.³²

For patients, the lived experience involves weeks of intravenous antibiotics, at least one and sometimes two surgeries, restricted activity while awaiting reimplantation, and the anxiety of knowing the infection could return. Older or frailer patients may face prolonged immobility that carries its own risks. The physical and emotional burden underscores why prevention strategies and early recognition matter so much: catching an infection at the pocket stage, before it spreads to leads and bloodstream, changes the entire trajectory of treatment and recovery.